Finex logo
Finex Intelligence

Market Signal Briefing

Real-time pulse of financial headlines curated from 2 premium feeds.

Last news saved at Dec 23, 04:21 44m ago Cron last ran Dec 23, 04:21 45m ago 2 sources live
Switch language
44,817 Stories ingested Auto-fetched market intel nonstop.
377 Distinct tickers Symbols referenced across the feed
crypton... Trending sources cryptonews • stocknewsapi
Hot tickers
BTC ETH XRP SOL AAVE DOGE
Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-11-05 08:24 1mo ago
2025-11-05 02:39 1mo ago
Sinopec Signs Deals Worth US$40.9 Billion at CIIE 2025 stocknewsapi
SNPMF
, /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") hosted a themed forum and a signing ceremony on November 4 at the 8th China International Import Expo (CIIE 2025). The Company signed purchasing contracts with 34 partners from 17 countries and regions, which totaled US$40.9 billion, including 24 products from 10 major categories, including crude oil, chemicals, equipment, materials, consumer goods and more. Since the first CIIE in 2018, Sinopec has signed orders exceeding a total of US$325 billion in eight sessions.

Sinopec Signs Deals Worth US$40.9 Billion at CIIE 2025.

Centered on the theme Technology Driven, AI Empowered: The Future of Energy, the forum focused on digital intelligence, technological innovation, new materials R&D, supply chain resilience enhancement, and exploring deeper international energy cooperation.

Zhao Dong, vice chairman and president of Sinopec, delivered a speech at the forum, which was moderated by Li Yonglin, director and senior vice president of Sinopec. Niu Shuanwen, director and senior vice president of Sinopec, attended the event and signed agreements with international partners.

"Sinopec is firmly committed to its primary mission of promoting high‑quality development. While continuing to consolidate the industrial foundation leveraging technological strength, the group also adheres to the principle of 'digital intelligence empowerment' to activate new engines of value creation, striving to advance the energy and chemical industry toward greater sophistication, intelligence, and sustainability," remarked Zhao Dong.

He emphasized that Sinopec's development is inseparable from the long‑term trust and strong support of global partners. Looking ahead to China's 15th Five‑Year Plan period, Zhao Dong outlined Sinopec's goal to work with all parties to strengthen scientific and technological innovation, break developmental bottlenecks, and build new industry advantages.

Zhao Dong also called for joint efforts to accelerate the pace of digital intelligence empowerment, promote deep integration of next‑generation information technology with the energy and chemical industry, and stimulate new drivers for industrial upgrading. Zhao Dong said Sinopec will expand green and low‑carbon cooperation, advancing clean and efficient use of traditional energy in parallel with the large‑scale development of new energy, thereby creating a sustainable development blueprint and a bright future for the energy and chemical industry.

Senior executives from leading firms—Datuk Sazali Hamzah (EVP & CEO Downstream, Petronas Chemicals Group), Axel Lorenz (CEO, Process Automation, Siemens), Aravind Yarlagadda (SVP, Industrial Solutions, Baker Hughes), and Audun M. Martinsen (Partner and Head of Energy Service Research, Rystad Energy)—delivered keynote speeches.

SOURCE SINOPEC
2025-11-05 08:24 1mo ago
2025-11-05 02:39 1mo ago
Alamos Gold: Top-Quality Gold Miner Trading Below Fair Value With Strong Organic Growth stocknewsapi
AGI
SummaryAlamos Gold remains a Buy, trading below fair value despite a recent production cut and strong gold price gains.AGI boasts a robust financial position, low-cost operations, and a promising organic growth pipeline, targeting ~700,000 ounces by 2027.Temporary setbacks such as the downtime at Magino and Island Gold are not fundamental issues and do not alter the company's long-term potential, but they came at a terrible time.Even if gold prices decline, AGI's organic growth should offset it, while potential for higher gold prices could unlock significant upside for the stock.Analyst’s Disclosure:I/we have a beneficial long position in the shares of AGI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You
2025-11-05 08:24 1mo ago
2025-11-05 02:41 1mo ago
Orsted Swings to Loss Following U.S. Stop-Work Order, But Stays Upbeat for Full Year stocknewsapi
DNNGY DOGEF
The renewable-energy company said it remained confident of reaching its full-year targets.
2025-11-05 08:24 1mo ago
2025-11-05 02:41 1mo ago
French satellite operator Eutelsat taps Imerys exec as next finance chief stocknewsapi
ETCMY EUTLF IMYSF
Eutelsat has appointed Sébastien Rouge as its new Chief Financial Officer, the French satellite operator said on Wednesday.
2025-11-05 08:24 1mo ago
2025-11-05 02:42 1mo ago
Nvidia deepens India focus with $2 billion Deep Tech Alliance partnership stocknewsapi
NVDA
Nvidia is expanding its footprint in India by joining a $2 billion investment alliance focused on deep technology, according to CNBC. As a founding member of the India Deep Tech Alliance (IDTA), the US chipmaker aims to mentor startups building solutions in semiconductors, artificial intelligence, biotechnology, space, robotics, and energy.
2025-11-05 08:24 1mo ago
2025-11-05 02:44 1mo ago
Johnson Controls Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts stocknewsapi
JCI
Johnson Controls International plc (NYSE:JCI) will release earnings results for the fourth quarter before the opening bell on Wednesday, Nov. 5.

Analysts expect the Cork, Ireland-based company to report quarterly earnings at $1.20 per share, down from $1.28 per share in the year-ago period. The consensus estimate for Johnson Controls' quarterly revenue is $6.33 billion, compared to $7.39 billion a year earlier, according to Benzinga Pro.

On Sept. 24, Johnson Controls announced the appointment of Todd Grabowski as vice president and president, Americas.

Shares of Johnson Controls fell 1.9% to close at $111.04 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

JP Morgan analyst Stephen Tusa maintained an Overweight rating and raised the price target from $105 to $125 on Oct. 15, 2025. This analyst has an accuracy rate of 69%.
Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and increased the price target from $112 to $119 on Oct. 9, 2025. This analyst has an accuracy rate of 84%.
Morgan Stanley analyst Chris Snyder maintained an Overweight rating and increased the price target from $115 to $125 on Aug. 21, 2025. This analyst has an accuracy rate of 77%.
RBC Capital analyst Deane Dray maintained a Sector Perform rating and increased the price target from $112 to $114 on July 30, 2025. This analyst has an accuracy rate of 69%.
Barclays analyst Julian Mitchell maintained an Equal-Weight rating and raised the price target from $100 to $101 on July 30, 2025. This analyst has an accuracy rate of 73%
Considering buying JCI stock? Here’s what analysts think:

Read This Next:

Top 2 Industrials Stocks You May Want To Dump This Quarter
Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2025-11-05 08:24 1mo ago
2025-11-05 02:46 1mo ago
Challenger Limited (CFIGY) Shareholder/Analyst Call Transcript stocknewsapi
CFIGF
Challenger Limited (OTCPK:CFIGY) Shareholder/Analyst Call November 4, 2025 5:30 PM EST

Company Participants

Mark Chen - General Manager of Investor Relations
Nick Hamilton - MD, CEO & Director
Alexandra Bell - Chief Financial Officer
Anton Kapel - Chief Executive of Insurance

Conference Call Participants

Freya Kong - BofA Securities, Research Division
Kieren Chidgey - UBS Investment Bank, Research Division
Siddharth Parameswaran - JPMorgan Chase & Co, Research Division
Julian Braganza - Goldman Sachs Group, Inc., Research Division
Lafitani Sotiriou - MST Financial Services Pty Limited, Research Division
Simon Fitzgerald - Jefferies LLC, Research Division
Andrei Stadnik - Morgan Stanley, Research Division
Marcus Barnard - Bell Potter Securities Limited, Research Division

Presentation

Mark Chen
General Manager of Investor Relations

Good morning, everyone, and welcome to those joining online to Challenger's market briefing on APRA's proposed capital standards for longevity Products. I'm Mark Chen, Challenger's General Manager of Investor Relations. We're coming to you today from our Martin Place head office in Sydney.

Before we begin, I would like to acknowledge the Gadigal people of the Eora Nation, the traditional custodians of the land on which we are hosting this event today and pay my respects to both elders, past and present.

Today's briefing will be followed by a Q&A session that will only be open to analysts and investors. To ask a question you'll need to have joined via the telephone. As a reminder, today's briefing is based on APRA's proposed capital standards issued last week. We are currently in consultation with APRA with written submissions on these proposed reforms due by 17th of December. As such, there are certain subjects we will be unable to provide responses to, which the teams are working on or that require Challenger Board or APRA approval. These are areas such as target ranges, risk appetite, asset allocation, capital allocation. We will use the session to provide points of clarification of guidance, including the use of illustrative

Recommended For You
2025-11-05 08:24 1mo ago
2025-11-05 02:49 1mo ago
Veris Residential: Shares Have Potential, But Are Fully Priced stocknewsapi
VRE
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-05 08:24 1mo ago
2025-11-05 02:52 1mo ago
M&S reveals cost of cyber attack as profit almost wiped out stocknewsapi
MAKSY
The cyber attack on high street department store Marks and Spencer is expected to directly cost roughly £136m.

The figure is only the cost of immediate incident systems response and recovery, as well as specialist legal
and professional services support.

Combined with a loss in sales, as the retailer's online systems were out of action from Easter into the summer, statutory profit before tax at the business has been nearly wiped out for the first half of the year.

This profit measure dropped from £391.9m last year to £3.4m this year.

About £100m is being claimed back in insurance for the cyberattack, M&S said in its market update.

This breaking news story is being updated and more details will be published shortly.

Please refresh the page for the latest version.

You can receive breaking news alerts on a smartphone or tablet via the Sky News app. You can also follow us on WhatsApp and subscribe to our YouTube channel to keep up with the latest news.
2025-11-05 08:24 1mo ago
2025-11-05 02:55 1mo ago
Kingman Minerals Prepares for Drilling at High-Grade Mohave Project amid Record Gold Prices stocknewsapi
KGSSF
November 05, 2025 2:55 AM EST | Source: Kingman Minerals Ltd.
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2025) - Kingman Minerals Ltd. (TSXV: KGS) (OTCQB: KGSSF) (FSE: 47A) ("Kingman" or the "Company") is pleased to update shareholders on the significant progress to date at its flagship Mohave Project in Mohave County, Arizona, which includes the historic Rosebud Mine. Given the current strength in the gold market, Kingman believes the Mohave Project is exceptionally well-positioned for near-term value creation.

Historic High-Grade District with Substantial Upside

The Mohave Project comprises 72 lode claims (1467 acres or 594 hectares), inclusive of the historic Rosebud Mine. The underground workings include over 2,300 feet of drifts, raises, and crosscuts. Historical (non-NI 43-101) data suggest a potential for up to 664,000 ounces of gold and 2.6 million ounces of silver across multiple parallel vein structures.1

Kingman's focus is to continue to replicate and validate these historic values, then expand and upgrade them according to modern exploration standards.

Modern Work Programs & High-Grade Sampling Results

Kingman has executed multiple phases of work to date, including two underground reconnaissance programs and two drilling phases, both confirming high-grade gold and silver intercepts at depth. Underground sampling from mineralized veins returned exceptional results, including 688 g/t Au and 468 g/t Ag over 0.18 m, and 252 g/t Au and 341 g/t Ag over 0.46 m.

Phase 1 Underground Reconnaissance & Sampling
Confirmed access to historic workings and collected high-grade channel and chip samples. A standout result was **252 g/t Au + 341 g/t Ag over 0.46 m** on the 100 ft level of the Rosebud Mine.2Phase 2 Underground Reconnaissance & Sampling
Expanded sampling efforts on the 100 ft and 200 ft levels, clearing debris to access lower levels, and sending assays to ALS Laboratories (method ME-GRA21).3Key highlights include:

SampleLevelWidth (m)Au (g/t) Ag (g/t) RB200-11100 ft, N Stope0.18 m **688 g/t****468 g/t**RB200-10100 ft, N Stope0.15 m 109 g/t 164 g/t RB200-13100 ft, N Stope0.28 m 70.5 g/t 93 g/t RB200-4 100 ft 0.25 m 2.88 g/t 133 g/t These values confirm the presence of bonanza-grade veins, supporting the historic high grades and underscoring the vertical and lateral continuity potential.3

This combination of strong assay results across multiple locations lays the foundation to validate, expand, and define the resource.

With gold prices at or near record levels and many analysts' forecasting further upside, projects with proven high-grade potential in stable jurisdictions are attracting increased investor attention. The Mohave Project's location in Arizona—with good infrastructure and a favorable mining climate—further strengthens its development profile.

By converting historic grades into NI 43-101-compliant resources in the near term, Kingman will proceed with extensive exploration work. The high grades seen in both Phase 1 and Phase 2, combined with the modelled continuity from 3D surveys, provide multiple pathways for upside—whether by expanding the known veins, identifying parallel structures, or exploring extensions downward.

"We are excited to advance work at Mohave and bring clarity to a district with truly exceptional grade potential," said Simon Studer, Interim CEO of Kingman Minerals Ltd. "Our underground sampling already underscores bonanza-grade zones in multiple places, and the updated mapping and digital modelling give us confidence in targeting these veins for drilling. With gold markets in a strong uptrend, we anticipate drilling to convert this potential into value for our shareholders."

TECHNICAL INFORMATION

The technical information in this website has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 and reviewed on behalf of the company by, Qualified Person: Bradley C. Peek, MSc. CPG Qualified Person for Kingman Minerals Ltd.

ABOUT

Kingman Minerals Ltd. (TSXV: KGS) is a publicly traded exploration and development company focused on precious metals in North America. The company's flagship project is the fully owned historic Rosebud Mine, located in the Music Mountains, Mohave County, Arizona. High-grade gold and silver veins were discovered in the area in the 1880's and were mined mainly in the late 20's and 30's. Underground development on the Rosebud property included a 400-foot shaft and approximately 2,500 feet of drifts, raises, and crosscuts. The company believes that to explore the full potential of the area, drilling and sampling along strike and depth extensions of existing and additional vein structures is essential.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements regarding, among other things, the completion transactions completed in the Agreement.Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, regulatory approval processes. Although Kingman believes that the assumptions used in preparing the forward-looking information in this news release are reasonable, including that all necessary regulatory approvals will be obtained in a timely manner, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Kingman disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable securities laws.

1: https://kingmanminerals.com/projects/mohave-project/?utm_source=chatgpt.com "Mohave Project"
2: https://finance.yahoo.com/news/2nd-sampling-program-results-mohave-065500480.html?utm_source=chatgpt.com "2nd Sampling Program Results Mohave Project Mine Shaft ..."
3: https://kingmanminerals.com/projects/mohave-project/2nd-phase-underground-reconnaissance-sampling-program/?utm_source=chatgpt.com "2nd Phase Underground Reconnaissance & Sampling"

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273234
2025-11-05 08:24 1mo ago
2025-11-05 02:56 1mo ago
The Baldwin Insurance Group, Inc. (BWIN) Q3 2025 Earnings Call Transcript stocknewsapi
BWIN
Q3: 2025-11-04 Earnings SummaryEPS of $0.31 misses by $0.00

 |

Revenue of

$365.39M

(7.80% Y/Y)

beats by $1.69M

The Baldwin Insurance Group, Inc. (BWIN) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST

Company Participants

Bonnie Bishop - Executive Director of Investor Relations
Trevor Baldwin - CEO & Non-Independent Director
Bradford Hale - Chief Financial Officer

Conference Call Participants

Charles Peters - Raymond James & Associates, Inc., Research Division
Charles Lederer - BMO Capital Markets Equity Research
Elyse Greenspan - Wells Fargo Securities, LLC, Research Division
Pablo Singzon - JPMorgan Chase & Co, Research Division
Andrew Andersen - Jefferies LLC, Research Division
Brian Meredith - UBS Investment Bank, Research Division
Thomas Mcjoynt-Griffith - Keefe, Bruyette, & Woods, Inc., Research Division

Presentation

Operator

Ladies and gentlemen, greetings, and welcome to the Baldwin Group Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Bonnie Bishop, Executive Director, Investor Relations. Please go ahead.

Bonnie Bishop
Executive Director of Investor Relations

Thank you. Welcome to the Baldwin Group's Third Quarter 2025 Earnings Call. Today's call is being recorded.

Third quarter financial results, supplemental information and Form 10-Q were issued earlier this afternoon and are available on the company's website at ir.baldwin.com. Please note that remarks made today may include forward-looking statements subject to various assumptions, risks and uncertainties, including, for example, our strategy with respect to our capital allocation in the future. The company's actual results may differ materially from those contemplated by such statements. For a more detailed discussion, please refer to the note regarding forward-looking statements in the company's earnings release and our most recent Form 10-Q, both of which are available on the Baldwin website.

During the call today, the company may also discuss certain non-GAAP financial measures. For a more detailed discussion of these non-GAAP financial measures and historical reconciliation to the most closely comparable GAAP measures, please refer to the

Recommended For You
2025-11-05 08:24 1mo ago
2025-11-05 02:58 1mo ago
Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential stocknewsapi
MBGPF
, /PRNewswire/ -- Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement comprises 19 European markets, enabling a coordinated launch across all key EU markets under the leading global antifungal brand Lamisil®.

The agreement covers 19 European markets, representing a total population of approximately 500 million people including all major EU countries and the United Kingdom ("Big 5") as well as the eleven countries where Terclara® is already approved but not yet launched. This provides Moberg Pharma the opportunity for a coordinated launch in all key European markets. Karo Healthcare will be responsible for marketing, distribution and sales throughout Europe. Financial terms are not disclosed, but the agreement includes royalties and compensation for delivered products.

"We are very pleased to enter this partnership with Karo Healthcare, which has a strong commercial presence across Europe. Launching MOB-015/Terclara® under the well-known Lamisil® brand gives us an exceptional opportunity to establish the product as the market leader also beyond Sweden and Norway," says Anna Ljung, CEO of Moberg Pharma.

"Moberg Pharma has developed a unique and clinically well-documented product. Being able to launch MOB-015/Terclara® under the Lamisil® brand is a perfect combination of scientific innovation and commercial strength that gives us a unique position in the market," says Christoffer Lorenzen, CEO of Karo.

The Lamisil® brand
Terbinafine, originally developed and launched by Novartis under the Lamisil® brand, has long been considered the gold standard treatment for skin and foot fungal infections such as athlete's foot and nail fungus. Lamisil® is present in more than 60 markets worldwide and has become synonymous with its active ingredient, terbinafine, while consistently standing at the forefront of antifungal research and innovation.

MOB-015/Terclara®, developed by Moberg Pharma, represents the next generation of terbinafine therapy – a new topical formulation. Oral treatment of nail fungus is associated with risks such as interactions with other medications and liver damage, which are avoided with topical treatment. Previous attempts at topical treatment with terbinafine have failed due to the difficulty of delivering a sufficient amount of the active substance through the nail. MOB-015 is the first topical treatment that has achieved mycological cure on par with oral treatment, with 76% of patients achieving mycological cure in the registration studies. It is therefore particularly satisfying to launch the product under the strong and fitting Lamisil® brand.

Launch and regulatory steps
Launching MOB-015/Terclara® under the Lamisil® brand, wherever possible, optimizes the product's chances to take a leading position in major European markets. However, the use of the Lamisil® brand for this pharmaceutical product requires approval by the respective national health authorities, which affects the timing of the launch. Both companies intend to initiate launch as soon as possible.

The companies will also collaborate to expand current marketing authorizations to additional countries as soon as feasible. For regulatory reasons, markets that are already approved have priority, since new countries cannot be added while a name change or other changes are being implemented.

Although the product will be launched under the Lamisil® brand, the connection to Moberg Pharma will be made clear through the marketing concept 'Powered by Terclara®'.

A partnership with strong European reach
Karo Healthcare is a leading European consumer healthcare company, backed by KKR, a leading global investment firm, and with ambitious growth plans across Europe. With established distribution in all major European pharmacy chains, Karo has the capacity to manage both prescription and over-the-counter products, including prescription-to-nonprescription (Rx-to-OTC) switches.

Through this partnership with Karo Healthcare, the product gains broad market coverage and effective distribution right from the outset, which would take Moberg Pharma time to build up on its own. While Moberg Pharma will not launch Terclara® on its own in Europe as part of this collaboration, the company still plans to play an active commercial role in other territories, particularly in the U.S., as part of its long-term strategy.

The agreement marks an important milestone in Moberg Pharma's commercial expansion and lays the foundation to establish MOB-015/Terclara® as the new market leader in the treatment of nail fungus across Europe.

About this information
Moberg Pharma is releasing this information in accordance with the EU's Market Abuse Regulation (MAR). The information was released for public distribution through the contact named below at 8.30 a.m. CET on November 5th, 2025.

For additional information, please contact:
Anna Ljung, CEO, Phone: +46 8 522 307 01, E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/moberg-pharma/r/moberg-pharma-and-karo-healthcare-enter-exclusive-license-agreement-for-mob-015-terclara-in-europe--,c4261942

The following files are available for download:

SOURCE Moberg Pharma
2025-11-05 08:24 1mo ago
2025-11-05 02:58 1mo ago
Marks & Spencer hikes dividend as cyber attack recovery almost complete stocknewsapi
MAKSY
Marks and Spencer Group PLC (LSE:MKS) reported stronger first-half profits than expected, after the retailer quickly settled its insurance claim at £100 million for the cyber attack that laid it low in the spring. 

The FTSE 100-listed group generated an adjusted pre-tax profit of £184.1 million in the 26 weeks to 27 September, down from £413.1 million last year as the cyber incident led to some empty shelves as systems were taken offline to thwart attackers.

Despite the attack, group sales jumped 22% to £7.97 billion.

Food sales, which increased 7.8% and generated an adjusted operating profit of £89.1 million as margins declined to 2.0% from 5.1%. In current trading, margins were said to now be almost back to normal.

Fashion, Home & Beauty sales declined 16.4%, but still made a profit from that division at £46.1 million despite margins falling to 2.7% from 12%. The recovery in this arm has been slower, the M&S said, "as systems complexity means it has taken time to smooth the flow of stock".

International sales also fell, down 11.6% with profit at £13.3 million, while Ocado Retail posted a £3.1 million operating loss before adjustments.

The cyber incident led to £101.6 million in related costs.

Reflecting the recovery, the board increased the interim dividend 20% to 1.2p.

“The first half of this year was an extraordinary moment in time for M&S,” said chief executive Stuart Machin. “In the second half, we expect profit to be at least in line with last year.”

In the fact of the disruption, he hailed further progress on the “Reshape for Growth” strategy, including a £340 million investment in its food supply chain and opening six new stores in the first half. A further 12 are planned before the end of the financial year.

Machin added: “Our plan to reshape M&S for long-term sustainable growth is unchanged, our ambitions are undimmed, and our determination to knuckle down and deliver is stronger than ever.”
2025-11-05 08:24 1mo ago
2025-11-05 02:59 1mo ago
Top Wall Street Forecasters Revamp Humana Expectations Ahead Of Q3 Earnings stocknewsapi
HUM
Humana Inc. (NYSE:HUM) will release earnings results for the third quarter before the opening bell on Wednesday, Nov. 5.

Analysts expect the Louisville, Kentucky-based company to report quarterly earnings at $2.82 per share, down from $4.16 per share in the year-ago period. The consensus estimate for Humana's quarterly revenue is $32.01 billion, compared to $29.4 billion a year earlier, according to Benzinga Pro.

On Oct. 28, Humana announced that its board declared a cash dividend to stockholders of 88.5 cents per share.

Shares of Humana rose 0.7% to close at $281.87 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

B of A Securities analyst Kevin Fishbeck maintained a Neutral rating and raised the price target from $280 to $300 on Oct. 10, 2025. This analyst has an accuracy rate of 66%.
Mizuho analyst Ann Hynes maintained an Outperform rating and increased the price target from $300 to $345 on Oct. 9, 2025. This analyst has an accuracy rate of 72%.
Barclays analyst Andrew Mok maintained an Equal-Weight rating and cur the price target from $315 to $245 on Oct. 3, 2025. This analyst has an accuracy rate of 62%.
RBC Capital analyst Ben Hendrix maintained an Outperform rating and increased the price target from $283 to $322 on Aug. 21, 2025. This analyst has an accuracy rate of 62%.
Argus Research analyst David Toung reiterated a Hold rating with a price target of $281.99 on Aug. 14, 2025. This analyst has an accuracy rate of 67%
Considering buying HUM stock? Here’s what analysts think:

Read This Next:

Top 2 Industrials Stocks You May Want To Dump This Quarter
Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2025-11-05 08:24 1mo ago
2025-11-05 03:00 1mo ago
Corero Network Security Builds on Q3 Execution with Major Q4 Wins and Product Breakthroughs stocknewsapi
DDOSF
Major customer renewal, global expansion, and new innovations position Corero for continued growth into 2026 LONDON , Nov. 5, 2025 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), a recognized leader in DDoS protection and champion of adaptive, real-time service availability, today reported accelerating global growth in Q3 2025, fueled by rising order intake and continued innovation across its SmartWall ONE™ platform, and began Q4 with a major renewal and expansion with a leading US cloud computing provider. Building on strong execution, Corero achieved $7.4 million in Q3 order intake (up from $6.0 million in Q3 2024) with new customer wins spanning the US, UK, Europe, Brazil, and Singapore.
2025-11-05 08:24 1mo ago
2025-11-05 03:00 1mo ago
Futu to Report Third Quarter 2025 Financial Results on November 18, 2025 stocknewsapi
FUTU
November 05, 2025 03:00 ET

 | Source:

Futu Holdings Limited

HONG KONG, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the third quarter ended September 30, 2025, before U.S. markets open on November 18, 2025.

Futu's management will hold an earnings conference call on Tuesday, November 18, 2025, at 7:30 AM U.S. Eastern Time (8:30 PM on the same day, Beijing/Hong Kong Time).

Please note that all participants will need to pre-register for the conference call, using the link

https://register-conf.media-server.com/register/BI87ab49c568d44b2da54051280cc03405.

It will automatically lead to the registration page of "Futu Holdings Ltd Third Quarter 2025 Earnings Conference Call," where details for RSVP are needed.

Upon registering, all participants will be provided in confirmation emails with participant dial-in numbers and personal PINs to access the conference call. Please dial in 10 minutes prior to the call start time using the conference access information.

Additionally, a live and archived webcast of this conference call will be available at https://ir.futuholdings.com/.

About Futu Holdings Limited

Futu Holdings Limited (Nasdaq: FUTU) is an advanced technology company transforming the investing experience by offering fully digitalized financial services. Through its proprietary digital platforms, Futubull and moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Company has embedded social media tools to create a network centered around its users and provide connectivity to users, investors, companies, analysts, media and key opinion leaders. The Company also provides corporate services, including IPO distribution, investor relations and ESOP solution services.

Investor Contact

Investor Relations
Futu Holdings Limited
[email protected]
2025-11-05 08:24 1mo ago
2025-11-05 03:01 1mo ago
Zscaler ThreatLabz Reveals 67% Jump in Android Malware and 40% of IoT Attacks Target Critical Industries and Hybrid Work stocknewsapi
ZS
Key Findings:

Critical infrastructure in the energy sector experienced a 387% increase in attacks compared to the previous yearIndia continues to be the top target for mobile attacks, with 26% of activityThe US remains the top target for IoT attacks, with 54% of activity SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today published the findings of its Zscaler ThreatLabz 2025 Mobile, IoT, and OT Threat Report, outlining how threat actors are leveraging malware attacks and constantly evolving their tactics. The report uncovered hundreds of malicious apps in the Google Play Store that have been downloaded over 40 million times, targeting users that are searching for productivity and workflow apps. Based on Zscaler's mobile telemetry dataset, the ThreatLabz team identified several emerging mobile threats and new malicious activity, providing valuable insights to help enterprises stay ahead of attackers in a mobile-first world.

Hundreds of malicious apps downloaded over 40 million times

Similar to last year, this year we again saw threat actors developing and releasing malicious applications targeting trusted marketplaces and hybrid work environments. The result, which the report reveals is a 67% year-over-year increase in Android malware transactions, reflects the continued risks of spyware and banking malware. ThreatLabz researchers identified 239 such applications hosted on the Google Play Store, which were collectively downloaded 42 million times.

A key distribution channel for this malware was the "Tools" category, disguising malicious applications as productivity and workflow tools. This tactic capitalizes on users' trust in functionality-driven applications–a trust that is particularly strong in hybrid and remote work settings where mobile devices are integral to professional tasks.

Manufacturing remains a top target for mobile and IoT attacks

ThreatLabz's analysis of Android attack volumes reveals that the Manufacturing and Energy sectors remain prime targets for cybercriminals due to the potential for significant returns. Notably, the energy sector experienced a substantial 387% increase in attacks compared to the previous year, highlighting an escalating threat to critical infrastructure and greater exploitation of vulnerabilities within these essential industries.

In the IoT landscape, the Manufacturing and Transportation sectors continue to be the most frequently targeted verticals. This year, each sector accounted for 20.2% of all observed IoT malware attacks, collectively representing over 40% of total incidents. This marks a shift from 2024, when Manufacturing alone represented 36% of total incidents, followed by Transportation at 14%. This suggests that while Manufacturing remains a critical target, threat actors are increasingly diversifying their efforts across other high-dependency IoT industries.

Most prevalent IoT malware

Roughly 40% of blocked transactions are linked to the Mirai family alone, and Mozi has overtaken Gafgyt as the second highest malware family. Together, Mirai, Mozi, and Gafgyt account for roughly 75% of all malicious payloads in IoT environments.

Mobile attacks cluster in India, US and Canada; US is the IoT threat epicenter at 54 percent

Worldwide, mobile threats have surged, with many of these attacks concentrated in three key regions: India, accounting for 26% of all mobile attacks, the United States at 15%, and Canada at 14%. India, in particular, experienced a significant 38% increase in mobile threat attacks compared to the previous year.

The top five countries that receive the most mobile malware traffic are:

India (26%)United States (15%)Canada (14%)Mexico (5%)South Africa (4%) The report also revealed that the US is both a hub for IoT activity (54.1%) and a primary target for malware attacks. The top five countries that receive the most IoT malware traffic are:

United States (54%)Hong Kong (15.%)Germany (6%)India (5%)China (4%) “Attackers are pivoting to areas with maximum impact. We’re seeing a YoY rise of 67% in malware targeting mobile devices and 387% in IoT/OT attacks on energy sectors often hosting critical infrastructure, which is a massive swing,” said Deepen Desai, EVP and Chief Security Officer at Zscaler. “A Zero Trust everywhere approach, combined with AI-powered threat detection, is imperative to reducing the attack surface, limit lateral movement, and provide organizations the defense they need against ever-evolving attacks.”

Additional highlights and new findings this year

A new backdoor called Android Void malware has infected 1.6 million Android-based TV boxes, primarily in India and BrazilNew Remote Access Trojan (RAT), Xnotice, was identified for targeting job seekers in the oil and gas industry, particularly in MENAAdware overtook the Joker malware family as the top mobile threat, with a leading 69% of cases, while Joker dropped to 23% of cases, from 38% last yearThreat actors are abandoning card-focused fraud in favor of mobile payments Defending against growing IoT, OT and Mobile threats

Zscaler Zero Trust Branch delivers comprehensive security and operational efficiency for branch offices, remote sites, and distributed networks, designed for environments that rely heavily on mobile, IoT, cellular IoT, and OT technologies. Using a cloud-native and AI-driven Zero Trust architecture, Zscaler aims to ensure all users, devices, and applications are safeguarded with continuous real-time verification and robust policy enforcement, regardless of their location relative to the traditional network perimeter.

Zscaler Cellular offers secure, scalable, and efficient connectivity as a service for IoT and mobile devices that rely on cellular connections. This solution, powered by the Zscaler Zero Trust Exchange™ platform, addresses the growing security challenges posed by billions of IoT devices and mobile endpoints, which traditional security methods often fail to secure effectively. It achieves this by enforcing granular policies, providing centralized visibility, and eliminating attack surfaces for all cellular traffic.

Download your copy

The 2025 Mobile, IoT, and OT Threat Report highlights the critical importance of securing mobile endpoints, IoT devices, and OT systems. Access the full report at https://www.zscaler.com/campaign/threatlabz-mobile-iot-ot-report.

Research Methodology
Mobile
The research methodology for this report includes analysis of mobile transactions and associated cyberthreats based on data collected from the Zscaler cloud between June 2024 and May 2025. The dataset comprises more than 20 million threat-related mobile transactions.

IoT/OT
The team focused their research on understanding the distinct attributes and activity of IoT devices via device fingerprinting (DFP) and analyzing the IoT malware threat landscape.

Device fingerprinting data from March 2025 to May 2025 included:

A complete inventory of devices, including device types and manufacturersThe volume and source of IoT device transactionsThe industries and geographies contributing to IoT traffic IoT malware threat data from June 2024 to May 2025 included:

The most active malware familiesThe industries and geographies most targeted by IoT attacksThe top attacked devices About Zscaler
Zscaler (NASDAQ: ZS) accelerates digital transformation so customers can be more agile, efficient, resilient, and secure. The Zscaler Zero Trust Exchange™ platform protects thousands of customers from cyberattacks and data loss by securely connecting users, devices, and applications in any location. Distributed across more than 160 data centers globally, the SASE-based Zero Trust Exchange is the world’s largest in-line cloud security platform.

Media Contact
Taylor Dunton, Senior Director, Public Relations, [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a9909238-c36f-4286-a7b6-5916db8e5847

Threatlabz 2025 Mobile, IoT, and OT Threat Report
2025 Threatlabz Mobile, IoT, and OT Threat Report-
2025-11-05 08:24 1mo ago
2025-11-05 03:05 1mo ago
Point and Funds Managed by Blue Owl Capital Close Oversubscribed $390 Million Home Equity Investment Rated Securitization stocknewsapi
OWL
Palo Alto, California, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Point, the leading home equity investment platform making homeownership more valuable and accessible, and funds managed by Blue Owl Capital (“Blue Owl”) announced today that they have completed a rated securitization of Point’s Home Equity Investment (“HEI”) assets, issuing $390 million of rated asset-backed securities (the “Transaction”), marking Point’s third securitization of 2025 and continuing the firm’s record of programmatic issuance.

The Transaction closed on October 28th, 2025. The issuer, Point Securitization Trust 2025-2, issued $254.2 million of senior class A-1 securities rated A (low) (sf), $46.6 million of mezzanine class A-2 securities rated BBB (low) (sf), $45.9 million of subordinate class B-1 securities rated BB (low) (sf), and $43.3 million of subordinate class B-2 securities rated B (high) (sf) (retained), all rated by Morningstar DBRS. A portion of the notes was acquired by accounts managed by an affiliate of Blue Owl. The Transaction attracted 29 unique investors, including eight new entrants to the Point securitization platform, resulting in over $1.6 billion in orders, and underscoring the continued institutional interest and confidence in Point’s program. Co-sponsoring the Transaction with a subsidiary of Blue Owl, Point was the originator of all the HEIs in the securitization and will continue to service the assets.

In addition to complying with U.S. credit risk retention rules, the Transaction is the first HEI securitization to include undertakings related to both the EU Securitization Regulation and the UK Securitization Framework, as well as the transparency requirements of the EU Securitization Regulation. These steps further position Point’s securitization platform to meet the standards of European and UK institutional investors, reflecting Point’s commitment to broadening global access to the HEI market.

“Building on the strong momentum of PNT 25-1, this transaction reflects growing confidence in home equity investments as a mainstream asset class,” said Eddie Lim, co-founder and CEO of Point. “As homeowners and investors continue to seek flexible, sustainable ways to unlock and deploy capital, Point is proud to lead with consistency, transparency, and execution.”

Since pioneering the HEI category in 2015, Point has closed six securitizations and continues to set benchmarks for liquidity, scalability, and transparency in alternative home equity financing. 

“This marks the third transaction that Blue Owl has co-sponsored alongside Point. We were able to combine legacy seasoned collateral we acquired earlier this year with new originations purchased directly from Point to issue the largest public HEI securitization to date,” said Ivan Zinn, Head of Alternative Credit at Blue Owl. “Blue Owl and Point have a longstanding relationship dating back to 2018, and we are excited to continue working with the Point team.”

Barclays Capital Inc. (“Barclays”) was the sole-structuring agent for the issuance. Barclays, Nomura Securities International Inc., and Cantor Fitzgerald & Co. were joint bookrunners on the Transaction, and East West Markets, LLC and StoneX Financial Inc. were co-managers on the Transaction.

About Point

Point is the leading home equity platform making homeownership more valuable and accessible. Point’s flagship product, the Home Equity Investment (HEI), empowers homeowners to unlock their equity to eliminate debt, get through periods of financial hardship, and diversify their wealth – without adding to their monthly expenses. Point has worked with more than 15,000 homeowners, unlocking more than $1.5 billion in home equity. Point’s HEI enables investors to access a previously untapped asset class – owner-occupied residential real estate. Founded in 2015 by Eddie Lim, Eoin Matthews, and Alex Rampell, Point is backed by top investors, including Westcap, Andreessen Horowitz, Ribbit Capital, Greylock Partners, Bloomberg Beta, Blue Owl Capital, Alpaca VC, and Prudential. The company is headquartered in Palo Alto, CA. For more information, please visit www.point.com

About Blue Owl

Blue Owl (NYSE: OWL) is a leading asset manager that is redefining alternatives®. With over $295 billion in assets under management as of September 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer institutional investors, individual investors, and insurance companies differentiated alternative investment opportunities that aim to deliver strong performance, risk-adjusted returns, and capital preservation.

Together with over 1,365 experienced professionals globally, Blue Owl brings the vision and discipline to create the exceptional. To learn more, visit www.blueowl.com.
2025-11-05 08:24 1mo ago
2025-11-05 03:13 1mo ago
Marks & Spencer Profits Plummet on Cyberattack stocknewsapi
MAKSY
Adjusted pretax profit plunged 55%, but the retailer said it expects a recovery in the second half of its fiscal year.
2025-11-05 08:24 1mo ago
2025-11-05 03:14 1mo ago
ONEOK: Get Ready For A Stronger Rally stocknewsapi
OKE
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-05 08:24 1mo ago
2025-11-05 03:15 1mo ago
E3 Lithium to Host Webinar on November 5, 2025 @ 9:00AM MT stocknewsapi
EEMMF
CALGARY, Alberta--(BUSINESS WIRE)--E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), (“E3 Lithium” or the “Company”) a leader in Canadian lithium development, reminds shareholders and interested stakeholders the Company is hosting a Webinar this morning, November 5, 2025, at 9:00am MT. During the presentation, Chris Doornbos, President and CEO, and members of the E3 Lithium management team will discuss:

Summary of Phase 1 Demonstration Facility achievements

Update on Phase 2 Demonstration Facility progress

Review of the recently closed equity financing

Positioning of E3 Lithium within the North American critical minerals strategy

Recent federal and provincial government initiatives supporting lithium development

Upcoming milestones for the Clearwater Project for Q4 2025 and 2026

Webinar Details:

Date: Wednesday, November 5, 2025

Time: 09:00 AM Mountain Time (11:00 AM Eastern Time)

Registration Link: Zoom (click here to log in at the time of the webinar; no need to register in advance)

Duration: 45 minutes presentation + 15 minutes Q&A

If you are having issues with the registration link, copy this address into your browser to be directed to the log in page: https://us02web.zoom.us/webinar/register/WN_o022pANsTUSsiD6uPUdTag

The webinar will be followed by a live Q&A session where attendees can submit questions in real-time. Participants are encouraged to submit questions in advance by emailing [email protected] to ensure they are reviewed during the webinar.

The webinar recording will be made available on the Company's website following the event.

ON BEHALF OF THE BOARD OF DIRECTORS

Chris Doornbos, President, CEO & Chair

E3 Lithium Ltd.

About E3 Lithium

E3 Lithium is a development company with a total of 21.2 million tonnes (Mt) of lithium carbonate equivalent (LCE) Measured and Indicated1 resources as well as 0.3 Mt LCE Inferred mineral resources2 in Alberta and 2.5 Mt LCE Inferred mineral resources3 in Saskatchewan. The Clearwater Project Pre-Feasibility Study outlined a 1.13 Mt LCE proven and probable mineral reserve with a pre-tax NPV(8%) of USD 5.2 Billion with a 29.2% IRR and an after-tax NPV(8%) of USD 3.7 Billion with a 24.6% IRR1.

1: The Clearwater Project NI 43-101 Pre-Feasibility Study, effective June 20, 2024 (the “PFS”), identified 16.2 Mt LCE (measured and indicated) and is available on the E3 Lithium website (www.e3lithium.ca/technical-reports/) and SEDAR+ (www.sedarplus.ca).

2: The mineral resource NI 43-101 Technical Report for the Garrington District Lithium Resource Estimate, effective June 25, 2025, identified 5.0 Mt LCE (measured and indicated) and 0.3 Mt LCE (inferred) and is available on the E3 Lithium website (www.e3lithium.ca/technical-reports/) and SEDAR+ (www.sedarplus.ca).

3: The mineral resource NI 43-101 Technical Report for the Estevan Lithium District, effective May 23, 2024, identified 2.5 Mt LCE (inferred) and is available on the E3 Lithium website (www.e3lithium.ca/technical-reports/) and SEDAR+ (www.sedarplus.ca).

Unless otherwise indicated, Kevin Carroll, P. Eng., Chief Development Officer and a Qualified Person under National Instrument 43-101, has reviewed and is responsible for the technical information contained on this news release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions or forward-looking information within the meaning of applicable securities laws. Forward-looking statements are frequently identified by such words as “believe”, “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend”, “project”, “potential”, “possible” and similar words referring to future events and results. Forward-looking statements are based on the current opinions, expectations, estimates and assumptions of management in light of its experience, and perception of historical trends, but such statements are not guarantees of future performance. All forward-looking information (including future-orientated financial information) is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of mineral exploration and development, fluctuating commodity prices, the effectiveness and feasibility of emerging lithium extraction technologies which have not yet been tested or proven on a commercial scale or on the Company’s brine, risks related to the availability of financing on commercially reasonable terms and the expected use of proceeds; operations and contractual obligations; changes in estimated mineral reserves or mineral resources; future prices of lithium and other metals; availability of third party contractors; availability of equipment; failure of equipment to operate as anticipated; accidents, effects of weather and other natural phenomena and other risks associated with the mineral exploration industry; the Company’s lack of operating revenues; currency fluctuations; risks related to dependence on key personnel; estimates used in financial statements proving to be incorrect; competitive risks and the availability of financing, as described in more detail in our recent securities filings available under the Company’s profile on SEDAR+ (www.sedarplus.ca). Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law.

More News From E3 LITHIUM LTD.
2025-11-05 08:24 1mo ago
2025-11-05 03:16 1mo ago
Paylocity Holding Corporation (PCTY) Q1 2026 Earnings Call Transcript stocknewsapi
PCTY
Q1: 2025-11-04 Earnings SummaryEPS of $1.75 beats by $0.18

 |

Revenue of

$408.17M

(12.46% Y/Y)

beats by $8.64M

Paylocity Holding Corporation (PCTY) Q1 2026 Earnings Call November 4, 2025 5:00 PM EST

Company Participants

Ryan Glenn - Chief Financial Officer
Steven Beauchamp - Executive Chairman of the Board
Toby Williams - President, CEO & Director

Conference Call Participants

Brad Reback - Stifel, Nicolaus & Company, Incorporated, Research Division
Mark Marcon - Robert W. Baird & Co. Incorporated, Research Division
Daniel Jester - BMO Capital Markets Equity Research
Connor Passarella
Sitikantha Panigrahi - Mizuho Securities USA LLC, Research Division
Sheldon McMeans - Barclays Bank PLC, Research Division
Jared Levine - TD Cowen, Research Division
Jacob Roberge - William Blair & Company L.L.C., Research Division
Ian Black
Jordan Boretz
Jessica Wang - Raymond James & Associates, Inc., Research Division
Kincaid LaCorte
Aleksandr Zukin - Wolfe Research, LLC
Matthew VanVliet - Cantor Fitzgerald & Co., Research Division
Jason Celino - KeyBanc Capital Markets Inc., Research Division
George Michael Kurosawa - Citigroup Inc., Research Division
Zachary Gunn - Financial Technology Partners LP
Madeline Brooks
Jacob Cody Smith - Guggenheim Securities, LLC, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Paylocity Holding Corporation First Quarter 2026 Fiscal Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Ryan Glenn, Chief Financial Officer. Please go ahead.

Ryan Glenn
Chief Financial Officer

Good afternoon, and welcome to Paylocity's earnings results call for the first quarter of fiscal '26, which ended on September 30, 2025. I'm Ryan Glenn, Chief Financial Officer. And joining me on the call today are Steve Beauchamp, Executive Chairman; and Toby Williams, President and CEO of Paylocity. Today, we will be discussing the results announced in our press release issued after the market closed. A webcast replay of this call will be available for the next 45 days on our website under the Investor Relations tab.

Recommended For You
2025-11-05 08:24 1mo ago
2025-11-05 03:16 1mo ago
AGC Inc. (ASGLY) Q3 2025 Earnings Call Transcript stocknewsapi
ASGLY
AGC Inc. (OTCPK:ASGLY) Q3 2025 Earnings Call November 5, 2025 1:00 AM EST

Company Participants

Kazumi Tamaki - Executive Officer and GM of Corporate Communications & Investor Relations
Shinji Miyaji - Senior EVP, CFO, CCO & Director

Presentation

Kazumi Tamaki
Executive Officer and GM of Corporate Communications & Investor Relations

Let us get started. Welcome to the earnings briefing of AGC Inc. for the third quarter of fiscal year 2025. I'm Kazumi Tamaki, General Manager, Corporate Communications and Investor Relations, serving as moderator. Today's attendees are Shinji Miyaji, Executive Vice President, Executive Officer and CFO; and Tomoyuki Shiokawa, Executive Officer, General Manager of Finance and Control Division. We will first have CFO Miyaji, provide an overview of the financial results for the third quarter, followed by a Q&A session. We are planning to finish at 3:45 p.m. Your cooperation is appreciated.

Without further ado, I ask CFO, Miyaji, to start his presentation.

Shinji Miyaji
Senior EVP, CFO, CCO & Director

Thank you. This is Shinji Miyaji, the CFO. Please turn to Page 3. The highlights. Net sales for the first 9 months totaled JPY 1,512.1 billion, down JPY 22.1 billion year-on-year. Positives included an improved product mix and pricing policies for automotive glass, increased shipments and pricing policies for Performance Chemicals and pricing policies for architectural glass in Europe and the Americas, while negatives included a PVC price decline, decreased shipments of EUV photo blanks and European architectural glass and the impact of last year's Russian business transfer.

Operating profit was JPY 94.8 billion, up JPY 0.8 billion on effects of profit improvement measures in displays and others despite the adverse impact of the aforementioned factors as well as higher raw materials and fuel costs. Net income attributable to the owners of the parent was up JPY 145.9 billion at JPY 39.5 billion

Recommended For You
2025-11-05 08:24 1mo ago
2025-11-05 03:17 1mo ago
Google's $32 billion deal for Wiz clears DOJ antitrust review, Wiz CEO tells WSJ stocknewsapi
GOOG GOOGL
The Google logo is pictured at the entrance to the Google offices in London, Britain January 18, 2019. REUTERS/Hannah McKay Purchase Licensing Rights, opens new tab

Nov 5 (Reuters) - Cybersecurity company Wiz has cleared a U.S. Justice Department (DOJ) antitrust review of its acquisition by Google-parent Alphabet

(GOOGL.O), opens new tab, Wiz CEO said in a Wall Street Journal event on Tuesday.

The deal, valued at about $32 billion, would be Alphabet's largest acquisition. It will integrate Wiz into Google's cloud unit, enhancing the company's cybersecurity solutions to help businesses mitigate critical risks.

Sign up here.

"Definitely, this is an important milestone, but we’re still in the journey between signing and closing," Wiz CEO Assaf Rappaport said, when asked about the DOJ review of the deal.

In June, Bloomberg had reported that the DOJ antitrust enforcers were reviewing whether Alphabet's planned acquisition the cybersecurity firm would illegally limit competition in the marketplace.

"We look forward to completing the review process in other jurisdictions. The acquisition of Wiz is expected to close in 2026, subject to customary closing conditions," a Google spokesperson told Reuters in an emailed statement.

The DOJ and Wiz did not immediately respond to Reuters requests for comment.

Reporting by Abu Sultan and Devika Nair in Bengaluru, Editing by Eileen Soreng

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-11-05 08:24 1mo ago
2025-11-05 03:21 1mo ago
Marks & Spencer steadies the ship after cyber attack. But questions linger over recovery pace stocknewsapi
MAKSY
Marks and Spencer Group PLC (LSE:MKS) shares slipped about 3% in early trading despite results that analysts described as “better than feared,” following a turbulent six months dominated by a major cyber attack that knocked its online operations offline for 46 days.

The retailer reported adjusted pre-tax profit of £184 million for the first half of its financial year, a sharp fall from £413 million a year ago but comfortably ahead of analysts’ forecasts of around £76 million.

That figure was boosted by a prompt £100 million insurance payout covering losses from the cyber incident in April, which crippled the group’s website and led to weeks of restricted trading.

Even so, the results underline how far M&S has come since its near-collapse a decade ago.

Shore Capital, which acts as house broker, said weaker businesses “would not have emerged as robust as M&S to the malevolent challenges” it faced this year.

The company expects to be back to full operational strength by the end of the current financial year, with its food division already close to pre-attack performance levels.

Chief executive Stuart Machin said the group had “so much more to do and so much opportunity ahead,” but the immediate focus remains on restoring momentum in its fashion and home arm, which was hit hardest when online trading stopped.

Food sales rose 7.8% in the half-year, helped by more shoppers and new product launches, though margins were squeezed by markdowns and waste.

By contrast, fashion, home and beauty sales fell 16% after online orders plunged 42%. The division’s operating profit tumbled to £46 million from £243 million a year earlier.

ShoreCap expects full-year adjusted pre-tax profit of £655 million, including the insurance settlement, and at least flat profit growth in the second half compared with last year’s £468 million. Underlying profit, excluding the payout, is forecast at £555 million.

The company raised its interim dividend by 20% to 1.2p a share, a move analysts said demonstrated management’s confidence in cash flow. Net cash stood at £176 million, although total debt, including leases, increased slightly to £2.5 billion.

Despite the disruption, M&S is pushing ahead with its store renewal programme. Fifteen shops opened in the first half, with another 20 planned by year-end, including two new full-line outlets in Bath and Bristol.

Investment in logistics and technology is also continuing, including a £340 million food distribution centre in Daventry set to open in 2029.

Still, the road ahead looks far from certain. ShoreCap trimmed its 2027 profit forecast by 2.5% amid fears of higher taxes and softer consumer demand after Chancellor Rachel Reeves’ warning that “we are all in this together". This is seen as a prelude to a Tresury raid on earnings.

M&S shares, at about 374p (down 10.5p), trade on roughly 11 times expected 2027 earnings, a discount to Next and Tesco. Analysts argue that ongoing progress could narrow that gap.

For now, today’s dip in the share price suggests investors are reserving judgment.

M&S may have weathered the cyber storm better than expected, but the next few months will show whether it can fully reclaim the digital momentum it worked so hard to build.
2025-11-05 07:24 1mo ago
2025-11-05 01:46 1mo ago
Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call Transcript stocknewsapi
SLNO
Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST

Company Participants

Anish Bhatnagar - Chairman, President, CEO & COO
Meredith Manning - Chief Commercial Officer
James MacKaness - CFO & Compliance Officer

Conference Call Participants

Brian Ritchie - Lifesci Advisors, LLC
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Tyler Van Buren - TD Cowen, Research Division
Moritz Reiterer - Guggenheim Securities, LLC, Research Division
Rick Miller - Cantor Fitzgerald & Co., Research Division
Yasmeen Rahimi - Piper Sandler & Co., Research Division
Leland Gershell - Oppenheimer & Co. Inc., Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division
James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division
Derek Archila - Wells Fargo Securities, LLC, Research Division
Yale Jen - Laidlaw & Company (UK) Ltd., Research Division
Katherine Dellorusso
Jade Montgomery

Presentation

Operator

Good afternoon, and thank you for standing by. Welcome to Soleno Therapeutics Third Quarter 2025 Financial and Operating Results Conference Call and webcast. [Operator Instructions]. As a reminder, today's webcast is being recorded.

I would now like to introduce Brian Ritchie of LifeSci Advisors. Please go ahead.

Brian Ritchie
Lifesci Advisors, LLC

Thank you. Good afternoon, everyone, and thank you for joining us to discuss Soleno Therapeutics Third Quarter 2025 financial and operating results.

Please note, we will be making certain forward-looking statements today. We refer you to Soleno's SEC filings for a discussion of the risks that may cause actual results to differ from the forward-looking statements.

On the call with me today for Soleno are Anish Bhatnagar, Soleno's Chairman and Chief Executive Officer; Meredith Manning, Soleno's Chief Commercial Officer; and Jim MacKaness, Soleno's Chief Financial Officer.

With that, I will now turn the call over to Anish.

Anish Bhatnagar
Chairman, President, CEO & COO

Thank you, Brian, and thank you, everyone, for joining us for our third quarter results call

Recommended For You
2025-11-05 07:24 1mo ago
2025-11-05 01:47 1mo ago
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount stocknewsapi
NVO
Danish pharmaceutical giant Novo Nordisk said Wednesday it is lowering its growth expectations for its key obesity and diabetes treatments.

Net profit for the quarter came in at 20 billion Danish kroner ($3.1 billion) in line with the 20.12 billion Danish kroner anticipated by analysts in a FactSet poll.

Diabetes and obesity care were a key growth driver following the uptake of Wegovy and Ozempic, however the company lowered its expectations for growth, citing prescription trends, competition and pricing pressure.

Sales of its blockbuster weight loss drug Wegovy rose 18% year-on-year to hit 20.35 billion Danish kroner in the three months to September, slightly below the 21.35 billion kroner expected by analysts.

watch now

Novo's Copenhagen-listed shares have tumbled more than 50% over the course of this year, as a slew of headwinds has shaken investor confidence in what was once Europe's most valuable firm.

Stock Chart IconStock chart icon

Novo Nordisk share price

Alongside a series of disappointing trial results, increasing competition in the obesity drug space and challenges arising from U.S. policies on drug pricing and tariffs, Novo has been contending with leadership shakeups and pushback against a key acquisition.

Analysts, as a result, have been mixed on the stock. Jefferies recently cut its rating to underperform while Berenberg is positive on the stock, saying Novo has hit "peak uncertainty."

"Novo's superior growth profile and best-in-class R&D returns warrants a higher valuation premium to its peers," the bank said.

Metsera bidNovo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from U.S. pharma giant Pfizer. On Monday, Pfizer said it had filed a second lawsuit against Novo and Metsera, arguing that Novo's bid for the smaller company was anticompetitive.

A spokesperson for Novo said in a statement that Pfizer's allegations were "false and without merit."

Novo then ramped up its bid for Metsera on Tuesday, saying it was now offering up to $10 billion compared to the earlier offer of around $9 billion.

"Novo Nordisk believes that the proposal, including the structure of the transaction, complies with all applicable laws and is in the best interest of patients who will benefit from our commitment to innovation, as well as Metsera's shareholders," the company said in a statement, noting that the deal was also subject to the term's of Pfizer's merger agreement with Metsera.

Metsera said on Tuesday that the revised offer was "superior" to a revised bid made by Pfizer.
2025-11-05 07:24 1mo ago
2025-11-05 01:48 1mo ago
Siemens Healthineers Reports Fall in Profits, Citing Tariffs stocknewsapi
SMMNY
Higher comparable revenue stemming from the transformation program of its diagnostics business was offset by a hit from U.S. tariffs.
2025-11-05 07:24 1mo ago
2025-11-05 01:50 1mo ago
Gold stocks set to shine in London as haven demand lifts bullion stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
London-listed gold miners are expected to attract strong interest at the open, after bullion prices rebounded sharply overnight. Investors returned to the haven asset amid a sell-off in global equities driven by mounting concerns over stretched valuations.

Spot gold was $3,970 an ounce in Asian trading, recovering from a near 2% drop the previous day.

The rebound came as government bonds rallied and the dollar steadied at a multi-month high, reflecting a shift in sentiment following the steepest decline in global stocks in almost a month.

Tuesday’s decline in bullion had followed comments from several Federal Reserve policymakers, who signalled caution around the need for further interest rate cuts, citing a still-elevated inflation outlook.

Their remarks prompted traders to reassess expectations for monetary easing ahead of further appearances from US central bankers this week.

Despite recent volatility, gold remains around 50% higher year-to-date, having touched a record last month. Analystst said the metal is likely to consolidate within a $3,800 to $4,050 range, but noted ongoing demand from central banks and private investors is likely to support prices in the longer term.

Silver and palladium also posted modest gains during the session.
2025-11-05 07:24 1mo ago
2025-11-05 01:51 1mo ago
Natural Gas and Oil Forecast: Brent Hovers at $64 While OPEC Output Plans Cloud Outlook stocknewsapi
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP
Scan QR code to install app

Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.Risk DisclaimersThis website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
Tokyo Metropolitan Government Selects Japan Airlines Consortium to Join First Phase of “eVTOL Implementation Program” Featuring Archer's Midnight Aircraft stocknewsapi
ACHR
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $ACHR #Archer--Today Archer Aviation Inc. (NYSE: ACHR) announced the Japan Airlines-led consortium, which features Archer's Midnight Aircraft, was selected by the Tokyo Metropolitan Government to participate in phase one of Tokyo's “eVTOL Implementation Project.” Phase one of the project will assess the market and build the operating ecosystem, leading up to planned demonstration flights over Tokyo Bay and river routes, which represents critical steps towards ramping comm.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
Wolters Kluwer 2025 Nine-Month Trading Update stocknewsapi
WTKWY
Wolters Kluwer 2025 Nine-Month Trading Update Alphen aan den Rijn, November 5, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its scheduled 2025 nine-month trading update. Highlights Full-year 2025 guidance reaffirmed.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
Caledonia Mining Corporation Plc Appointment of July Ndlovu as Independent Non-Executive Director stocknewsapi
CMCL
ST HELIER, Jersey, Nov. 05, 2025 (GLOBE NEWSWIRE) -- (NYSE AMERICAN, AIM and VFEX: CMCL) - Caledonia Mining Corporation Plc ("Caledonia" or "the Company") is pleased to announce the appointment of Mr July Ndlovu to the board of directors of the Company (“the Board”) as an independent non-executive director.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
CelLBxHealth PLC Presents Proof-of-Concept Study stocknewsapi
ANPCY
CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conference Parsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA (prostate) GUILFORD, SURREY AND PLYMOUTH MEETING, PA / ACCESS Newswire / November 5, 2025 / CELLBXHEALTH plc (AIM:CLBX)(OTCQX:ANPCY), a global leader in circulating tumour cell (CTC) intelligence, announces the presentation of a proof-of-concept study using a Roche Tissue Diagnostics workflow at the 16th World ADC conference, San Diego, USA (Nov 3-6). The World ADC Conference is the largest global event dedicated to antibody-drug conjugates (ADCs), attracting over 1,400 attendees focused on advancing targeted cancer therapies.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
Coca-Cola Europacific Partners plc Announces Q3 Trading Update & Interim Dividend Declaration stocknewsapi
CCEP
UXBRIDGE, ENGLAND / ACCESS Newswire / November 5, 2025 / Trading Update for the Third Quarter ended 26 September 2025 & Interim Dividend Declaration Solid third quarter; reaffirming full-year guidance Change vs 2024 Revenue Volume (UC)[2] Revenue per UC[1],[2],[3] Comparable Volume[1] Revenue per UC[1],[2],[3] FXN[1],[3] revenue Revenue Q3 2025 Europe €4,194m 701m €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216m 311m €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410m 1,012m €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 Europe €11,665m 1,947m €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019m 997m €4.23 11.5% (1.6)% 9.1% 3.9% CCEP €15,684m 2,944m €5.39 3.7% 1.7% 4.5% 3.3% Change vs 2024 Adjusted comparable revenue[4] Adjusted comparable volume (UC)[4] Adjusted comparable revenue per UC[4] Adjusted comparable volume[4] Adjusted comparable revenue per UC[4] Adjusted comparable FXN revenue[4] Adjusted comparable revenue[4] Q3 2025 Europe €4,194m 701m €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216m 311m €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410m 1,012m €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 Europe €11,665m 1,947m €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019m 997m €4.23 0.8% 2.3% 2.1% (2.8)% CCEP €15,684m 2,944m €5.39 0.3% 3.4% 2.7% 1.5% Damian Gammell, Chief Executive Officer, said: "2025 continues to be a solid year for CCEP, reflecting our great brands, great people, great execution and strong relationships with our brand partners and customers. We've delivered another quarter of volume growth in Europe, despite softer consumer demand.
2025-11-05 07:24 1mo ago
2025-11-05 02:00 1mo ago
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities stocknewsapi
EVO SDZNY
Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD business Strong scientific advancements of co-developed asset pipeline: Expecting up to four molecules in clinical phase II in next six to nine months Signing of landmark industry transaction with Sandoz on 04 November, resulting in payments potentially over US$ 650 m plus royalties on portfolio of up to 10 biosimilar molecules 2025 guidance and 2028 outlook confirmed HAMBURG, DE / ACCESS Newswire / November 5, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) today announced its business update for 9M 2025, illustrating the ongoing systematic execution of its strategy. In the D&PD segment, the market for early drug discovery services remained soft, while strategic partnerships are on track and Evotec records strong progress in its partnered asset pipeline.
2025-11-05 07:24 1mo ago
2025-11-05 02:03 1mo ago
3M: Caution Is Still Needed After Sales Growth At Multiyear Highs (Rating Upgrade) stocknewsapi
MMM MMMM
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-05 07:24 1mo ago
2025-11-05 02:05 1mo ago
M&S' first-half profit hammered by impact of cyber hack stocknewsapi
MAKSY
A Marks and Spencer (M&S) logo is seen on the outside of a store in Cheshire, Britain August 18, 2020. REUTERS/Jason Cairnduff Purchase Licensing Rights, opens new tab

LONDON, Nov 5 (Reuters) - British retailer Marks & Spencer reported a 55.4% slide in first-half underlying profit, reflecting the impact on sales and margins of an April cyber hack that forced it to suspend online clothing orders for seven weeks and also hit food availability.

M&S

(MKS.L), opens new tab, one of the biggest names on the UK high street, said it made adjusted profit before tax of 184.1 million pounds ($247.1 million) in the six months to September 27, down from 413.1 million pounds in the same period last year.

Sign up here.

In May, M&S estimated the cyberattack would cost it about 300 million pounds in lost operating profit in its full year to March 2026, although it hoped to halve that impact through insurance, cost control and trading actions.

It said on Wednesday it had received insurance proceeds of 100 million pounds.

It also booked 167.8 million pounds of adjusting items, which included 101.6 million pounds of cyberattack related costs.

The 141-year-old group was forced to suspend taking online clothing orders for nearly two months and click and collect services for nearly four. Clothing and food availability in stores was also hit, while additional waste and logistics costs were incurred.

"We are confident we will be recovered and back on track by the financial year-end," M&S said.

"In the second half we therefore anticipate profit at least in line with last year, as the residual effects of the incident continue to reduce in the coming months."

($1 = 0.7451 pounds)

Reporting by James Davey, Editing by Paul Sandle

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-11-05 07:24 1mo ago
2025-11-05 02:05 1mo ago
CellBxHealth teams up with Roche in cancer testing breakthrough stocknewsapi
RHHBY
CelLBxHealth PLC (AIM:CLBX, NSX:ANPCY) has unveiled early results from a study that links its cancer cell detection technology with Roche’s widely used diagnostic equipment, a step that could make blood-based cancer testing easier to integrate into hospital laboratories.

The Guildford-based company, which focuses on analysing circulating tumour cells, live cancer cells that break away from tumours and travel in the bloodstream, presented its findings at the World ADC Conference in San Diego, the leading global event for antibody-drug conjugates (ADCs).

The proof-of-concept study showed that CellBxHealth’s Parsortix platform is compatible with Roche’s BenchMark ULTRA automated staining system.

This system, a mainstay of hospital pathology labs, can process up to 95 patient samples a minute roughly 50 million a year, and is used worldwide to analyse tissue samples for disease markers.

In the study, CellBxHealth’s samples were tested for three major cancer targets: HER2 in breast cancer, TROP2 in lung cancer and PSMA in prostate cancer.

The results showed that Roche’s automated system successfully identified these proteins using blood-derived cancer cells, matching the results achieved by traditional manual staining methods.

Peter Collins, chief executive, said: “We are pleased to present initial results on our proof-of-concept study undertaken using Roche Tissue Diagnostics' workflow.

"It is well known that targeted treatments that utilise biomarkers improve patient outcomes. As such, this study highlights the importance of targeted antigen expression on CTCs and their relevance for potentially guiding ADC therapy selection in real time.”

The findings suggest that analysing tumour cells circulating in the blood could one day provide a safer, faster, and less invasive alternative to traditional biopsies. Unlike tissue samples, blood tests can be repeated over time, giving doctors a clearer picture of how a patient’s cancer evolves during treatment.

ADCs are a fast-growing area of cancer medicine that use antibodies to deliver chemotherapy drugs directly to tumour cells, sparing healthy tissue.

By helping identify which patients are most likely to respond to these drugs, CellBxHealth’s approach could add an important new tool to the development of targeted therapies.
2025-11-05 07:24 1mo ago
2025-11-05 02:06 1mo ago
Kratos Defense & Security Solutions, Inc. (KTOS) Q3 2025 Earnings Call Transcript stocknewsapi
KTOS
Q3: 2025-11-04 Earnings SummaryEPS of $0.14 beats by $0.02

 |

Revenue of

$347.60M

(25.99% Y/Y)

beats by $25.38M

Kratos Defense & Security Solutions, Inc. (KTOS) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST

Company Participants

Marie Mendoza - Senior VP, General Counsel & Secretary
Eric DeMarco - CEO, President & Director
Deanna Lund - Executive VP, CFO & Director

Conference Call Participants

Ellen Page - Jefferies LLC, Research Division
Seth Seifman - JPMorgan Chase & Co, Research Division
Michael Ciarmoli - Truist Securities, Inc., Research Division
Michael Crawford - B. Riley Securities, Inc., Research Division
Jan-Frans Engelbrecht - Robert W. Baird & Co. Incorporated, Research Division
Jonathan Siegmann - Stifel, Nicolaus & Company, Incorporated, Research Division
Anthony Valentini - Goldman Sachs Group, Inc., Research Division
Kenneth Herbert - RBC Capital Markets, Research Division
Colin Canfield - Cantor Fitzgerald & Co., Research Division
Andre Madrid - BTIG, LLC, Research Division
Austin Moeller - Canaccord Genuity Corp., Research Division
Peter Skibitski - Alembic Global Advisors
Joseph Gomes - NOBLE Capital Markets, Inc., Research Division

Presentation

Operator

Good day, and welcome to the Kratos Defense & Security Solutions Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Marie Mendoza, Senior VP and General Counsel. Please go ahead.

Marie Mendoza
Senior VP, General Counsel & Secretary

Thank you. Good afternoon, everyone. Thank you for joining us for the Kratos Defense & Security Solutions Third Quarter 2025 Conference Call. With me today is Eric DeMarco, Kratos' President and Chief Executive Officer; and Deanna Lund, Kratos' Executive Vice President and Chief Financial Officer.

Before we begin the substance of today's call, I'd like everyone to please take note of the safe harbor paragraph that is included at the end of today's press release. This paragraph emphasizes the major uncertainties and risks inherent in the forward-looking statements we will make this afternoon. Please keep these uncertainties and risks in mind as we

Recommended For You
2025-11-05 07:24 1mo ago
2025-11-05 02:07 1mo ago
Gold (XAUUSD) & Silver Price Forecast: Markets Brace for ADP Data and Fed Signals stocknewsapi
AAAU DGL DGP GLD GLDM IAU IAUF OUNZ UGL
Metal’s modest uptick was largely driven by short-covering and safe-haven demand amid volatile equity markets. “It’s selective bargain buying as investors hedge against near-term volatility,” said Jigar Trivedi, senior analyst at Reliance Securities.

Focus Turns to U.S. Economic Data
The ADP report, expected to show a 32,000 job gain following last month’s 32,000 decline, is being closely watched as a barometer for labor market health ahead of Friday’s official jobs report. Stronger-than-expected data could temper hopes for a December rate cut, currently priced at 69% probability, down from over 90% a week earlier, according to CME’s FedWatch Tool.

The ISM Services PMI is forecast at 50.7, slightly above the previous 50.0, signaling a stable but subdued expansion in the services sector.

Any upside surprise could reinforce the Fed’s cautious tone, keeping interest rates elevated for longer, a scenario that typically weighs on non-yielding assets like gold and silver.

Despite higher yields and a strong dollar, analysts note that geopolitical uncertainty and concerns over global growth continue to underpin long-term demand for precious metals. Silver, often seen as both an industrial and investment metal, tracked gold’s movement, benefiting from renewed speculative interest.

“The broader narrative remains one of caution,” said a market strategist at ANZ Research. “While the Fed’s tone has shifted away from aggressive easing, persistent inflation and soft data could still drive renewed interest in gold and silver as defensive assets.”
2025-11-05 07:24 1mo ago
2025-11-05 02:07 1mo ago
Offshore wind group Orsted turns to net loss in Q3 following US woes under Trump stocknewsapi
DNNGY DOGEF
A view shows the logo of the company Orsted at its offices in Gentofte, Denmark September 5, 2025. REUTERS/ Tom Little/File Photo Purchase Licensing Rights, opens new tab

CompaniesCOPENHAGEN, Nov 5 (Reuters) - Orsted

(ORSTED.CO), opens new tab, the world's biggest offshore wind farm group, swung to a quarterly net loss of 1.70 billion Danish crowns ($265,50 million), it said on Wednesday, hit by U.S. President Donald Trump's trade policies and resistance to renewable energy.

Orsted's shares have plummeted 85% from their 2021 peak, hit by soaring costs and supply chain disruptions, as well as challenges in the United States where Trump sought to halt several ongoing developments and suspended new licensing.

Sign up here.

Orsted saw impairment losses of 1.8 billion crowns in the third quarter.

"The negative development was driven by increased tariffs in the U.S. and negative impact from the stop-work order on Revolution Wind, partly offset by decreasing interest rates," the company said in a statement.

The company's net loss for the July to September period was smaller than the average expectation of a 1.95 billion crowns deficit in a company-provided poll of analysts, but significabtly down from a year-ago profit of 5.17 billion crowns.

Meanwhile, its profit before interest, tax, depreciation and amortisation (EBITDA), excluding new partnerships and cancellation fees, came in at 3.06 billion crowns for the period, lagging an average poll forecast of 4.0 billion crowns.

($1 = 6.4029 Danish crowns)

Reporting by Stine Jacobsen and Louise Rasmussen, editing by Terje Solsvik

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-11-05 07:24 1mo ago
2025-11-05 02:08 1mo ago
BMW Expects Strong Demand in 2026 After Earnings Boosted by Lower Costs stocknewsapi
BAMXF BMWYY
The carmaker said it was on track to meet its full-year targets, with strong demand for the new iX3 model expected to drive growth next year
2025-11-05 07:24 1mo ago
2025-11-05 02:08 1mo ago
Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade stocknewsapi
ONSS
, /PRNewswire/ -- Onassis Holding Corp (OTC: ONSS) a US public company pioneering cellular rejuvenation and longevity biotechnology, is pleased to announce the appointment of Esq. Paz Itzhaki-Weinberger to its Advisory Board. Paz will lead the company's strategy on international law, trade, and cross border corporate affairs.

Paz Itzhaki-Weinberger combines deep experience in technology, law, and international business. He has held senior roles at Microsoft Corporation, managed multiple hi-tech ventures. As both an engineer and a lawyer, he has practiced at one of Israel's leading law firms and founded PIWLAW, recognized among the Top 200 Law Firms Worldwide (2014–2025) by Legals Finest.

Currently the CEO and Chairman of IWC Limited, Itzhaki-Weinberger previously led PatentsFund.com and continues to advise technology firms on IPO and M&A transactions. He holds degrees in Computer Science and Law and is fluent in English, Hebrew, Japanese, German, and Arabic.

Itzhaki-Weinberger is a member of the Israel Bar Association, the American Bar Association International Law Division, and The Law Society of England and Wales, as well as a Senior Member of IEEE and a board member of the Israel-Britain Chamber of Commerce.

About Onassis Holdings Corp.

Onassis Holdings Corp. (OTC: ONSS) is a US public company pioneering biotechnology for cellular rejuvenation and longevity. Through strategic collaborations and world-class science, Onassis aims to bring regenerative medicine innovations to the global market.

Media Contact
Investor Relations Department
Onassis Holdings Corp.
[email protected]
39 Broadway, New York, NY 10006
516-620-6794

Logo: https://mma.prnewswire.com/media/1708529/Onassis_Holdings_Corp_Logo.jpg

SOURCE Onassis Holdings Corp
2025-11-05 07:24 1mo ago
2025-11-05 02:08 1mo ago
Caledonia Mining appoints ex-Thungela boss July Ndlovu to board stocknewsapi
CMCL
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) has appointed July Ndlovu, the former chief executive of South Africa’s Thungela Resources, as an independent non-executive director, bringing almost three decades of mining experience to the London-listed gold producer.

Ndlovu, who has held senior roles at Anglo American Platinum and other major miners, joins the Jersey-based company as it looks to expand its operations in Zimbabwe and beyond.

His background spans both technical and corporate leadership, with a focus on large-scale project development, safety and sustainability.

At Thungela, he oversaw the company’s transformation into one of South Africa’s largest thermal coal exporters following its spin-off from Anglo American in 2021.

Earlier in his career, he served as executive head of process at Anglo American Platinum, where he managed operations producing a significant share of the world’s platinum group metals.

Ndlovu currently sits on the board of AECI, a mining and chemicals group with operations in 20 countries, where he chairs the remuneration and human capital committee. He also previously chaired the boards of Unki Mine and Anglo American Zimbabwe.

John Kelly, Caledonia’s chairman, said: “We are very pleased to welcome July to the board as an independent non-executive director. His extensive and broad-based experience in scaling and transforming businesses in the mining sector brings valuable perspective as we execute our next stage of growth.”
2025-11-05 07:24 1mo ago
2025-11-05 02:11 1mo ago
Unilever's Magnum Spinoff Sets Date for IPO After U.S. Shutdown Delay stocknewsapi
UL
The company will list on the Euronext Amsterdam, NYSE and London Stock Exchanges on Dec. 6, after finding a way to push forward despite the U.S. government shutdown.
2025-11-05 07:24 1mo ago
2025-11-05 02:13 1mo ago
Union Jack Oil reports result from latest Oklahoma well stocknewsapi
UJOGF
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF) has reported a 'disappointing and unexpected' result from its latest well in central Oklahoma failed to produce commercial quantities of oil, despite initial signs of promise.

The AIM-listed company, which focuses on onshore oil and gas projects in the UK and the US, said its Sark well reached a total depth of 5,391 feet, with logs indicating potential hydrocarbons in the Prue sandstone layer.

However, after a 30-day production test, the site did not yield commercially viable results.

Post-drilling analysis suggested that while the well encountered a valid geological structure, the trap that would have held oil in place had been breached, preventing accumulation.

David Bramhill, Union Jack’s executive chairman, said: “Following the drilling of four successful discoveries in Oklahoma to date, this is an unexpected and disappointing result.

"Our US interests, with income from Moccasin, the Andrews Field and mineral royalties, continue to be profitable and we look forward to continuing our Oklahoma drilling programme.”

Union Jack holds a 53% stake in the Sark project. The company’s portfolio in the US continues to generate income, providing support for ongoing exploration despite the setback.
2025-11-05 07:24 1mo ago
2025-11-05 02:15 1mo ago
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering stocknewsapi
GH
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million aggregate principal amount of 0% convertible senior notes due 2033 (the “notes”) in a private offering (the “convertible notes offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Th.
2025-11-05 07:24 1mo ago
2025-11-05 02:16 1mo ago
Nanosonics Limited (NNCSF) Shareholder/Analyst Call Transcript stocknewsapi
NNCSF
Steven Sargent

I think we're good to get going. We're good, Computershare. Thank you. Appreciate that. Good morning, ladies and gentlemen. My name is Steve Sargent, and I'm the Non-Executive Chairman of Nanosonics Limited. I would like to extend a warm welcome to our shareholders today here at the company's headquarters in Macquarie Park in Sydney and also to those shareholders joining us online. It's my privilege to Chair this 19th Annual General Meeting of the company.

I would also like to acknowledge the traditional owners of the various lands on which we're meeting today, and pay our respects to all Aboriginal elders, past and present, and acknowledge today's Aboriginal communities who are the custodians of these lands. With me in the room here today, I'm joined by the Nanosonics' Board of Directors, our Company Secretary and representatives of the company's auditor, Ernst & Young.

I've been advised by the Company Secretary that we have a quorum for this meeting, and I, therefore, declare the meeting open. The number of valid proxies received by 11:00 a.m. on Monday, the 3rd of November, was 330 proxies, representing over 221 million shares or 72.79% of the company's approximately 304 million shares on issue.

In accordance with the Corporations Act, the minutes of this meeting will record for each resolution, the total number of proxies exercisable by all proxies validly appointed, the directions in which the proxy forms and the results of the polling.

I would like to take the opportunity to introduce the Board and the company secretary and the company's auditors. So up the front here, we have our
2025-11-05 07:24 1mo ago
2025-11-05 02:17 1mo ago
Vestas Wind Systems Earnings Rise, Narrows Guidance stocknewsapi
VWDRY
It now expects between 18.5 billion euros and 19.5 billion euros in 2025 revenue partly reflecting lower expected earnings in its service division.